[Ip-health] Re: IGWG II: Limitation on Diseases

[Judit Rius Sanjuan]

It seems the footnote 1 may be coming back, they are currently
discussing it in one of the drafting rooms we (NGOS) do not have access to.

Judit Rius Sanjuan wrote:
> We have been informed that yesterday night one of the drafting group
> agreed to eliminate the footnote 1 included in the Secretariat Draft
> Global Strategy and Plan of Action.
>
> These are very good news because the footnote 1 included a
> unjustifiable limitation by listing the diseases that will be the
> focus of this global strategy and plan of action:
>
> Footnote eliminated: "The Commission=92s definitions of Type I, Type II
> and Type III diseases, and the specific diseases on which this draft
> strategy focuses, are as follows: Type I diseases are incident in both
> rich and poor countries, with large numbers of vulnerable populations
> in each. The strategy will focus on the following Type I diseases,
> increasingly prevalent in developing countries: diabetes,
> cardiovascular disease and cancer. Type II diseases are incident in
> both rich and poor countries, but with a substantial proportion of the
> cases in poor countries. For the purposes of the strategy, the focus
> is on HIV/AIDS and tuberculosis. Type III diseases are those that are
> overwhelmingly or exclusively incident in developing countries. For
> the purposes of the strategy, the focus is on the nine neglected
> infectious diseases that disproportionately affect poor and
> marginalized populations prioritized by the UNICEF/UNDP/World Bank/WHO
> Special Programme for Research and Training in Tropical Diseases:
> Chagas disease, dengue and dengue haemorrhagic fever, leishmaniasis,
> leprosy, lymphatic filariasis, malaria, onchocerciasis,
> schistosomiasis and human African trypanosomiasis."
>


--
Judit Rius Sanjuan
Attorney
judit.rius@keionline.org

Knowledge Ecology International (KEI)
www.keionline.org / www.cptech.org
1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673